It looks like 2018 will be another busy year for the Mass Torts Section. Read more
The next Xarelto federal bellwether case has been selected, but a trial date has not yet been set. Read more
Janssen has exclusive rights to market Xarelto in the United States, while Bayer markets and sells Xarelto outside the United States. Read more
Lawyers for the Plaintiffs state that they will continue to press forward with the legal claims of thousands of innocent victims of Xarelto. Read more
Xarelto carries a significant risk of severe, uncontrolled internal bleeding. Read more
Trial is now underway in a New Orleans Federal Court in the first Xarelto bellwether trial. Read more
The ability to measure Xarelto’s effect on a patient’s blood can identify patients at high risk of bleeding. Read more
The lawyers in our Mass Torts Section will continue to review and file cases involving serious injuries or death related to Xarelto use. Read more
I mentioned the Xarelto litigation briefly, but more needs to be said on this litigation. Read more
Lawyers in our Mass Torts Section have been very busy. Read more
If you would like to subscribe to the Jere Beasley Report digital edition, simply visit our Subscriptions page and provide the necessary information or call us at 800-898-2034.
Attorney Advertising - Prior results do not guarantee a similar outcome.